Education
About Us
Working with TipRanks
Follow Us
Perseus Proteomics, Inc. (JP:4882)
:4882
Total Valuation
Perseus Proteomics, Inc. has a market cap or net worth of ¥5.00B. The enterprise value is ¥4.42B.
Market Cap¥5.00B
Enterprise Value¥4.42B
Share Statistics
Perseus Proteomics, Inc. has 14,749,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,749,500
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Perseus Proteomics, Inc.’s return on equity (ROE) is -0.63 and return on invested capital (ROIC) is -49.11%.
Return on Equity (ROE)-0.63
Return on Assets (ROA)-0.50
Return on Invested Capital (ROIC)-49.11%
Return on Capital Employed (ROCE)-0.49
Revenue Per Employee4.82M
Profits Per Employee-36.19M
Employee Count25
Asset Turnover0.07
Inventory Turnover3.07
Valuation Ratios
The current PE Ratio of Perseus Proteomics, Inc. is ―. Perseus Proteomics, Inc.’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value7.33
Price to FCF0.00
Price to Operating Cash Flow-38.31
PEG Ratio―
Income Statement
In the last 12 months, Perseus Proteomics, Inc. had revenue of 120.38M and earned -904.80M in profits. Earnings per share was -63.41.
Revenue120.38M
Gross Profit104.05M
Operating Income-829.70M
Pretax Income-902.34M
Net Income-904.80M
EBITDA-899.49M
Earnings Per Share (EPS)-63.41
Cash Flow
In the last 12 months, operating cash flow was -155.77M and capital expenditures -25.96M, giving a free cash flow of -181.73M billion.
Operating Cash Flow-155.77M
Free Cash Flow-181.73M
Free Cash Flow per Share-12.32
Dividends & Yields
Perseus Proteomics, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.90
52-Week Price Change-52.03%
50-Day Moving Average400.02
200-Day Moving Average536.87
Relative Strength Index (RSI)30.28
Average Volume (3m)407.28K
Important Dates
Perseus Proteomics, Inc. upcoming earnings date is Nov 7, 2025, TBA (Confirmed).
Last Earnings DateAug 14, 2025
Next Earnings DateNov 7, 2025
Ex-Dividend Date―
Financial Position
Perseus Proteomics, Inc. as a current ratio of 14.22, with Debt / Equity ratio of 0.00%
Current Ratio14.22
Quick Ratio14.18
Debt to Market Cap0.00
Net Debt to EBITDA1.85
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Perseus Proteomics, Inc. has paid 2.46M in taxes.
Income Tax2.46M
Effective Tax Rate>-0.01
Enterprise Valuation
Perseus Proteomics, Inc. EV to EBITDA ratio is -9.82, with an EV/FCF ratio of -11.12.
EV to Sales73.39
EV to EBITDA-9.82
EV to Free Cash Flow-11.12
EV to Operating Cash Flow-12.28
Balance Sheet
Perseus Proteomics, Inc. has ¥1.88B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of -¥1.88B billion.
Cash & Marketable Securities¥1.88B
Total Debt¥0.00
Net Cash-¥1.88B
Net Cash Per Share-¥127.39
Tangible Book Value Per Share¥100.38
Margins
Gross margin is 86.14%, with operating margin of -689.26%, and net profit margin of -751.65%.
Gross Margin86.14%
Operating Margin-689.26%
Pretax Margin-749.61%
Net Profit Margin-751.65%
EBITDA Margin-747.24%
EBIT Margin-749.61%
Analyst Forecast
The average price target for Perseus Proteomics, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast27.46%
EPS Growth Forecast20.63%